A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas

Saved in:
Bibliographic Details
Published in:Blood advances 2023-02, Vol.7 (3), p.314-316
Main Authors: Rindone, Giovanni, Aroldi, Andrea, Bossi, Elisa, Verga, Luisa, Zambrotta, Giovanni, Tarantino, Sara, Piazza, Rocco, Mussolin, Lara, Chiarle, Roberto, Gambacorti-Passerini, Carlo
Format: Article
Language:English
Subjects:
Anaplastic Lymphoma Kinase
Crizotinib - adverse effects
Humans
Lymphoma
Receptor Protein-Tyrosine Kinases
Research Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2473-9529
2473-9537
DOI:10.1182/bloodadvances.2022007538